Literature DB >> 3542456

Comparison of insulin levels after injection by jet stream and disposable insulin syringe.

J I Malone, S Lowitt, N P Grove, S C Shah.   

Abstract

Intermediate-acting biosynthetic human (NPH) insulin was administered by disposable insulin syringe into the right upper thigh of nine insulin-dependent diabetic youths. Seven days later, the same amount and type of NPH insulin was given in the same anatomic site with a Medi-Jector II, which delivers insulin as a jet stream. Blood was collected before insulin injection and at hourly intervals subsequently for the measurement of glucose and insulin. The total serum insulin measured before the first morning dose with the needle and syringe and the Medi-Jector II was 41.2 +/- 10.7 microU/ml and 46.2 +/- 10.7 microU/ml, respectively. During the next 9 h, the areas under the respective total insulin curves were not different, but the area under the free-insulin curve after jet injection was greater than the free-insulin area after needle injection (P less than .01). The ratio of free/total serum insulin was 0.31 +/- 0.02 after needle injection and 0.40 +/- 0.03 after jet injection (P less than .0025). The peak of total insulin concentration occurred 4.2 h after jet injection of NPH: 1 h earlier than the peak after needle injection. The plasma glucose at time zero was 197 +/- 15 mg/dl before needle injection and 242 +/- 19 mg/dl before jet injection. Although the diet consumed by each subject on the 2nd study day was identical to that of the 1st day, the mean glucose increase was greater after needle-injected insulin than after jet-spray injection. This indicates that the greater amount of free insulin observed after jet-injected insulin had a direct effect in lowering the plasma glucose. Jet injection may reduce insulin requirements by increasing the availability of free insulin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3542456     DOI: 10.2337/diacare.9.6.637

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  11 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Visualization of injection depot after subcutaneous administration by syringe and needle-free device (Medi-Jector): first results with magnetic resonance imaging.

Authors:  C J Partsch; E von Büren; B Kühn; W G Sippell; G Brinkmann
Journal:  Eur J Pediatr       Date:  1997-11       Impact factor: 3.183

Review 3.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

4.  Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.

Authors:  Jingxuan Pan; Chun Chen; Yanli Jin; Enrique Fuentes-Mattei; Guermarie Velazquez-Tores; Juliana Maria Benito; Marina Konopleva; Michael Andreeff; Mong-Hong Lee; Sai-Ching Jim Yeung
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

5.  The Absorption of Needle-Free Insulin Aspart Through Jet Injector in Different Body Parts of Healthy Individuals.

Authors:  Qi Pan; Lina Zhang; Aimin Gu; Dongni Yu; Xiaoxia Wang; Yan Zhou; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

6.  Risks of jet injection of insulin in children.

Authors:  G E Theintz; P C Sizonenko
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

Review 7.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 8.  Ultrafast-acting insulins: state of the art.

Authors:  Lutz Heinemann; Douglas B Muchmore
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

Review 9.  Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.

Authors:  Murugan Prasathkumar; Robert Becky; Salim Anisha; Chenthamara Dhrisya; Subramaniam Sadhasivam
Journal:  Biotechnol Lett       Date:  2022-02-04       Impact factor: 2.461

10.  Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Authors:  Elsemiek E C Engwerda; Evertine J Abbink; Cees J Tack; Bastiaan E de Galan
Journal:  Diabetes Care       Date:  2011-06-29       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.